NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

EPL and Indovida Sign Definitive Agreements to Merge, Creating a $1 Billion Revenue Entity

Motilal Oswal's research report highlights a significant development in the consumer packaging industry, as EPL and Indovida, a subsidiary of Indorama Ventures Ltd, have entered into definitive agreements to merge. The transaction will result in the creation of a $1 billion revenue entity with a combined valuation of $2 billion. This merger will form one of the largest consumer packaging platforms in emerging markets, allowing the combined entity to expand its global reach, accelerate growth, and enhance margins and returns.

Indovida: A Leading Global Rigid PET Packaging Platform

Indovida is a prominent global rigid PET packaging company with 19 facilities across nine countries, primarily located in Southeast Asia and Africa. The company derives approximately 90% of its revenue from emerging markets and operates mainly in preforms, which account for about 75% of its revenue. Indovida's strong customer relationships, driven by high service quality, experienced management, reliable raw material access, and a diversified geographic footprint, have contributed to its success.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Valuation and Outlook

As part of the merger, EPL is valued at approximately $1.2 billion, representing a 70% premium to its closing price on March 26, 2026. Indovida India, on the other hand, is valued at approximately $700 million, which is a 35% discount to EPL's multiple. In terms of valuation multiples, EPL is trading at approximately 10.3x FY28E EPS of INR19.9 and 5x FY28E EV/EBITDA. Motilal Oswal values the stock at 14x FY28E EPS, arriving at a target price of INR270. The research firm reiterates its BUY rating on the stock.

CompanyFY28E EPS MultipleFY28E EV/EBITDA Multiple
EPL10.3x (INR19.9)5x
Target Price (Motilal Oswal)14x (INR270)-

Investor Takeaway

Investors should consider the potential benefits of the merger between EPL and Indovida.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.